Cullinan Therapeutics, Inc. Insider Trading
CGEM
Insiders sold $2.56M and bought nothing on the open market.
64% of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Jun 2022.
Get an email when CGEM's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan | 4,000 | $12.36 | 49K | 2.5% | Form 4 |
| Sep 8 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan | 8,000 | $21.57 | 173K | 4.8% | Form 4 |
| Aug 13 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan | 30,000 | $20.26 | 608K | 16% | Form 4 |
| Jul 6 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan | 8,000 | $17.82 | 143K | 4.7% | Form 4 |
| May 5 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan 2 parts | 8,000 | $14.62 average | 117K | 4.6% | Form 4 |
| Mar 5 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan | 8,000 | $15.68 | 125K | 4.5% | Form 4 |
| Feb 25 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan | 1,780 | $14.14 | 25K | 1.0% | Form 4 |
| Feb 23 – 24 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan 2 parts | 5,353 | $14.31 average | 77K | 2.9% | Form 4 |
| Feb 24 | Nadim Ahmed President and CEO | SoldNo plan | 13,515 | $14.47 | 196K | 3.3% | Form 4 |
| Feb 24 | Jeffrey Alan Jones Chief Medical Officer | SoldNo plan | 4,582 | $14.47 | 66K | 2.8% | Form 4 |
| Feb 24 | Jacquelyn L Sumer Chief Legal Officer | SoldNo plan | 3,601 | $14.47 | 52K | 2.7% | Form 4 |
| Feb 20 | Mary Kay Fenton Chief Financial Officer | SoldNo plan | 4,398 | $13.62 | 60K | 3.4% | Form 4 |
| Feb 20 | Jeffrey Alan Jones Chief Medical Officer | SoldNo plan | 4,982 | $13.62 | 68K | 2.9% | Form 4 |
| Feb 20 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan 2 parts | 11,742 | $14.08 average | 165K | 6.1% | Form 4 |
| Feb 20 | Jacquelyn L Sumer Chief Legal Officer | SoldNo plan | 3,742 | $13.62 | 51K | 2.8% | Form 4 |
| Feb 20 | Nadim Ahmed President and CEO | SoldNo plan | 16,381 | $13.62 | 223K | 3.9% | Form 4 |
| Feb 12 | Jennifer Michaelson Chief Scientific Officer | SoldNo plan | 416 | $12.03 | 5K | 0.3% | Form 4 |
| Jan 22 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan | 4,000 | $12.30 | 49K | 3.0% | Form 4 |
| Dec 23, 2025 | Nadim Ahmed President and CEO | SoldNo plan | 9,922 | $10.01 | 99K | 2.3% | Form 4 |
| Dec 19, 2025 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan | 1,345 | $10.01 | 13K | 1.0% | Form 4 |
| Dec 18, 2025 | Jacquelyn L Sumer Chief Legal Officer | SoldNo plan | 3,480 | $9.67 | 34K | 2.5% | Form 4 |
| Dec 18, 2025 | Jeffrey Alan Jones Chief Medical Officer | SoldNo plan | 4,632 | $9.67 | 45K | 2.7% | Form 4 |
| Dec 18, 2025 | Jennifer Michaelson Chief Scientific Officer | SoldNo plan | 2,898 | $9.67 | 28K | 2.1% | Form 4 |
| Dec 12, 2025 – Dec 15, 2025 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan 2 parts | 3,143 | $12.23 average | 38K | 2.2% | Form 4 |
| Nov 24, 2025 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan | 4,000 | $12.30 | 49K | 2.8% | Form 4 |
| Oct 28, 2025 | Weston Nichols Large holder | Bought | 165,667 | $8.40 | $1.39M | 1.9% | Form 4 |
| Oct 14, 2025 – Oct 17, 2025 | Lynx1 Capital Management LP Large holder | Bought 4 parts | 248,749 | $8.46 average | $2.1M | 1.5% | Form 4 |
| Oct 8, 2025 – Oct 10, 2025 | Lynx1 Capital Management LP Large holder | Bought 3 parts | 1,459,641 | $6.73 average | $9.83M | 9.9% | Form 4 |
| Feb 25, 2025 | Jeffrey Alan Jones Chief Medical Officer | SoldNo plan | 4,895 | $8.53 | 42K | 2.7% | Form 4 |
| Feb 25, 2025 | Jennifer Michaelson Chief Scientific Officer | SoldNo plan | 3,756 | $8.53 | 32K | 2.6% | Form 4 |
| Feb 25, 2025 | Nadim Ahmed President and CEO | SoldNo plan | 12,529 | $8.53 | 107K | 2.8% | Form 4 |
| Feb 25, 2025 | Jacquelyn L Sumer Chief Legal Officer | SoldNo plan | 3,756 | $8.53 | 32K | 2.7% | Form 4 |
| Jan 6, 2025 | Jennifer Michaelson Chief Scientific Officer | Sold10b5-1 plan | 4,000 | $12.51 | 50K | 4.0% | Form 4 |
| Dec 24, 2024 | Nadim Ahmed President and CEO | SoldNo plan | 8,400 | $11.87 | 100K | 3.1% | Form 4 |
| Dec 18, 2024 | Jennifer Michaelson Chief Scientific Officer | SoldNo plan | 4,693 | $11.41 | 54K | 4.5% | Form 4 |
| Dec 18, 2024 | Jeffrey Alan Jones Chief Medical Officer | SoldNo plan | 4,632 | $11.41 | 53K | 3.9% | Form 4 |
| Dec 18, 2024 | Jacquelyn L Sumer Chief Legal Officer | SoldNo plan | 3,482 | $11.41 | 40K | 3.7% | Form 4 |
| Dec 12, 2024 | Jennifer Michaelson Chief Scientific Officer | SoldNo plan | 3,489 | $12.52 | 44K | 3.2% | Form 4 |
- Nov 510b5-1 planJennifer MichaelsonChief Scientific Officer · sold 4,000 at $12.3649K2.5% of stake
- Sep 810b5-1 planJennifer MichaelsonChief Scientific Officer · sold 8,000 at $21.57173K4.8% of stake
- Aug 1310b5-1 planJennifer MichaelsonChief Scientific Officer · sold 30,000 at $20.26608K16% of stake
- Jul 610b5-1 planJennifer MichaelsonChief Scientific Officer · sold 8,000 at $17.82143K4.7% of stake
- May 510b5-1 planJennifer MichaelsonChief Scientific Officer · sold 8,000 at avg $14.62117K4.6% of stake
- Mar 510b5-1 planJennifer MichaelsonChief Scientific Officer · sold 8,000 at $15.68125K4.5% of stake
- Feb 2510b5-1 planJennifer MichaelsonChief Scientific Officer · sold 1,780 at $14.1425K1.0% of stake
- Feb 23 – 2410b5-1 planJennifer MichaelsonChief Scientific Officer · sold 5,353 at avg $14.3177K2.9% of stake
- Feb 24No planNadim AhmedPresident and CEO · sold 13,515 at $14.47196K3.3% of stake
- Feb 24No planJeffrey Alan JonesChief Medical Officer · sold 4,582 at $14.4766K2.8% of stake
- Feb 24No planJacquelyn L SumerChief Legal Officer · sold 3,601 at $14.4752K2.7% of stake
- Feb 20No planMary Kay FentonChief Financial Officer · sold 4,398 at $13.6260K3.4% of stake
- Feb 20No planJeffrey Alan JonesChief Medical Officer · sold 4,982 at $13.6268K2.9% of stake
- Feb 2010b5-1 planJennifer MichaelsonChief Scientific Officer · sold 11,742 at avg $14.08165K6.1% of stake
- Feb 20No planJacquelyn L SumerChief Legal Officer · sold 3,742 at $13.6251K2.8% of stake
- Feb 20No planNadim AhmedPresident and CEO · sold 16,381 at $13.62223K3.9% of stake
- Feb 12No planJennifer MichaelsonChief Scientific Officer · sold 416 at $12.035K0.3% of stake
- Jan 2210b5-1 planJennifer MichaelsonChief Scientific Officer · sold 4,000 at $12.3049K3.0% of stake
- Dec 23, 2025No planNadim AhmedPresident and CEO · sold 9,922 at $10.0199K2.3% of stake
- Dec 19, 202510b5-1 planJennifer MichaelsonChief Scientific Officer · sold 1,345 at $10.0113K1.0% of stake
- Dec 18, 2025No planJacquelyn L SumerChief Legal Officer · sold 3,480 at $9.6734K2.5% of stake
- Dec 18, 2025No planJeffrey Alan JonesChief Medical Officer · sold 4,632 at $9.6745K2.7% of stake
- Dec 18, 2025No planJennifer MichaelsonChief Scientific Officer · sold 2,898 at $9.6728K2.1% of stake
- Dec 12, 2025 – Dec 15, 202510b5-1 planJennifer MichaelsonChief Scientific Officer · sold 3,143 at avg $12.2338K2.2% of stake
- Nov 24, 202510b5-1 planJennifer MichaelsonChief Scientific Officer · sold 4,000 at $12.3049K2.8% of stake
- Oct 28, 2025Weston NicholsLarge holder · bought 165,667 at $8.40$1.39M1.9% of stake
- Oct 14, 2025 – Oct 17, 2025Lynx1 Capital Management LPLarge holder · bought 248,749 at avg $8.46$2.1M1.5% of stake
- Oct 8, 2025 – Oct 10, 2025Lynx1 Capital Management LPLarge holder · bought 1,459,641 at avg $6.73$9.83M9.9% of stake
- Feb 25, 2025No planJeffrey Alan JonesChief Medical Officer · sold 4,895 at $8.5342K2.7% of stake
- Feb 25, 2025No planJennifer MichaelsonChief Scientific Officer · sold 3,756 at $8.5332K2.6% of stake
- Feb 25, 2025No planNadim AhmedPresident and CEO · sold 12,529 at $8.53107K2.8% of stake
- Feb 25, 2025No planJacquelyn L SumerChief Legal Officer · sold 3,756 at $8.5332K2.7% of stake
- Jan 6, 202510b5-1 planJennifer MichaelsonChief Scientific Officer · sold 4,000 at $12.5150K4.0% of stake
- Dec 24, 2024No planNadim AhmedPresident and CEO · sold 8,400 at $11.87100K3.1% of stake
- Dec 18, 2024No planJennifer MichaelsonChief Scientific Officer · sold 4,693 at $11.4154K4.5% of stake
- Dec 18, 2024No planJeffrey Alan JonesChief Medical Officer · sold 4,632 at $11.4153K3.9% of stake
- Dec 18, 2024No planJacquelyn L SumerChief Legal Officer · sold 3,482 at $11.4140K3.7% of stake
- Dec 12, 2024No planJennifer MichaelsonChief Scientific Officer · sold 3,489 at $12.5244K3.2% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with CGEM
Held by ETFs
CGEM is in 40 US ETFs. The largest of them, with CGEM's weight in each:
Spot a number that looks wrong? Check it in CGEM's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CGEM
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.